Skip to content

Computational Design and Virtual Screening of Enumeration-Generated Benzothiazinone Derivatives as Cholinesterase Inhibitors Using Pharmacophore Modelling, Molecular Dynamics, DFT and ML-Based Predictive Modelling Analysis

Sep 2026 · Journal of Computational Biophysics and Chemistry · 0 citations

TL;DR

Overall, the integrated AChE/BChE docking, MMGBSA, molecular dynamics, pharmacophore modelling, DFT, ADMET, and machinelearning analyses highlight benzothiazinone derivatives, particularly 1d, 1k, and 1a, as promising cholinesterase-targeting candidates and provide valuable structural insights for the rational development of potential therapeutic agents against Alzheimer’s disease.

Abstract

Acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) are key cholinergic targets implicated in Alzheimer’s disease (AD), and simultaneous modulation of these enzymes represents a promising strategy for addressing cholinergic dysfunction. In the present study, a comprehensive computational approach was employed to investigate benzothiazinone derivatives as potential cholinesterase inhibitors. Molecular docking of a virtual library against AChE (PDB ID: 6O4W) identified several compounds with favorable binding affinities, among which compounds 1d, 1k, and 1a were prioritized based on their overall docking performance and binding interactions. Compound 1d exhibited a favorable AChE docking score of -9.441 kcal/mol, comparable to the reference drug donepezil. To assess their binding affinity to BChE, the selected compounds were docked with BChE (PDB ID: 5DYW). This resulted in docking scores of -8.796 kcal/mol for 1a, -8.859 kcal/mol for 1k, and -8.748 kcal/mol for 1d. Further MMGBSA binding free-energy calculations confirmed these compounds' strong binding, emphasizing the role of hydrophobic and van der Waals interactions in stabilizing the complexes. The stability of the selected ligand–protein complexes were subsequently evaluated through 100 ns molecular dynamics simulations, with compounds 1k and 1d exhibiting stable interactions within the respective binding sites. Pharmacophore modelling identified the AHRRR_1 hypothesis, comprising one hydrogen-bond acceptor, one hydrogen-bond donor, and three aromatic ring features, with a selectivity score of 1.985 and a survival score of 5.975. Density functional theory (DFT) calculations revealed favorable electronic characteristics, including suitable HOMO–LUMO distributions and charge-transfer properties. ADMET analysis indicated favourable pharmacokinetic profiles for several derivatives, while CatPredbased machine-learning analysis predicted inhibition constants (Ki) in the micromolar range, suggesting moderate to strong binding potential. Overall, the integrated AChE/BChE docking, MMGBSA, molecular dynamics, pharmacophore modelling, DFT, ADMET, and machinelearning analyses highlight benzothiazinone derivatives, particularly 1d, 1k, and 1a, as promising cholinesterase-targeting candidates and provide valuable structural insights for the rational development of potential therapeutic agents against Alzheimer’s disease.

View source

Similar papers

Open access Aug 2026

Structure-based Design and Computational Evaluation of Spiropyrrolidine Derivatives as Novel Acetylcholinesterase Inhibitors for Alzheimer’s Disease

Several synthesized spiropyrrolidine compounds exhibited favorable binding interactions with key active site residues and showed promising drug-like properties, which may serve as potential leads for the development of novel AChE inhibitors and may provide new insights for therapeutic strategies in Alzheimer's disease.

Paranthaman Shamala, M. N. Shaik, P. B. et al. · 0 citations
Open access Sep 2026

Molecular Docking Analysis and Comparative Evaluation of Phytochemical Compounds Against Acetylcholinesterase and Butyrylcholinesterase Enzymes in Alzheimer's Disease

Background: Acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) regulate cholinergic neurotransmission and remain relevant targets for symptomatic treatment and ligand discovery in Alzheimer's disease. This study comparatively screened 16 phytochemicals from six medicinal plants against human AChE and BChE. Me...

S. Yılmaz, Şeyma Yaşar · 0 citations
Oct 2026

Virtual screening, structural optimization, computational studies, and biological evaluation of quinoline derivatives as selective butyrylcholinesterase inhibitors.

Butyrylcholinesterase (BChE) has been recognized as an important therapeutic target for neurodegenerative diseases, including Alzheimer's disease (AD). In this study, a molecular docking-based virtual screening strategy led to the identification of a novel BChE inhibitor, Hit 5 (eqBChE IC50 = 4.1 ± 0.19 μM, hBChE IC50 ...

Hua-Ke Gao, Fei-Fei Li, Qin Liu et al. · 0 citations
Open access Sep 2026

Computationally Guided Design of New Naphthalene-Oxazole-Hydrazone Derivatives as Potential HDAC Inhibitors: ADME Assessment, Molecular Docking, Molecular Dynamics, and MM/GBSA Analysis

Computational findings suggest that the designed naphthalene–oxazole–hydrazone derivatives emerged as the most promising candidate among the designed derivatives based on the computational analyses that warrant further synthesis and biological evaluation.

Noor Waleed · 0 citations
Aug 2026

Design, synthesis, biological activity and computational simulation evaluation of pyrimidine-2-aminoacetamide derivatives as cholinesterase inhibitors

Compound 17v represents a promising lead compound for anti-Alzheimer's therapy and may possess multi-target neuroprotective potential and a favorable preliminary safety profile, supporting its further investigation as a potential therapeutic candidate for Alzheimer’s disease.

Yi-Xuan Wang, Shi-Hao Qin, Qiang Liu et al. · 0 citations
Open access Aug 2026

In Silico Optimization of Dihydropteridine Derivatives Targeting PLK1 for Glioblastoma: An Integrated QSAR, Docking, and Molecular Dynamics Study

Computational findings support the prioritization of X14 for further experimental validation in glioblastoma therapy, and generally favorable ADMET profiles were observed, hepatotoxicity alerts were predicted for all compounds, which represents an important limitation supporting the prioritization of X14.

Youssef Briach, M. Er-rajy, Jamal Elkhabchi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.